Kenvue Stock Quote: A Comprehensive Guide to Investing

Kenvue is a biopharmaceutical company that has been making waves in the industry, and as such, its stock quote is a topic of interest for many investors.

Kenvue's stock is listed on the NASDAQ exchange under the ticker symbol KVUE.

Investors can check the current stock price and other relevant information on websites like Yahoo Finance or Google Finance.

The stock price can fluctuate based on various market and company-specific factors, such as earnings reports and clinical trial results.

Kenvue's financial data shows a steady growth in revenue, with estimates suggesting a 3.84% dividend yield in 2025. This is a significant increase from the 1.86% dividend yield in 2023.

The company's equity ratio has decreased from 73.29% in 2022 to 40.25% in 2023, indicating a higher debt-to-equity ratio. This is reflected in the debt ratio, which increased from 26.71% in 2022 to 59.75% in 2023.

Kenvue's net profit is expected to increase from $2,323 in 2025 to $2,824 in 2028, with an average annual growth rate of 4.5%. The company's net profit adjusted is also expected to increase, from $2,309 in 2025 to $2,824 in 2028.

Here is a breakdown of Kenvue's financial data:

Kenvue's earnings per share (EPS) is expected to increase from $1.21 in 2025 to $1.47 in 2028, with an average annual growth rate of 5.6%. The company's price-to-earnings ratio (P/E ratio) is expected to decrease from 17.77 in 2025 to 14.54 in 2028.

Kenvue, the world's largest pure-play consumer health company, recently announced its participation in the Morgan Stanley Global Consumer & Retail Conference in New York City.

The event will feature a fireside chat with CEO Thibaut Mongon and CFO Paul Ruh on Wednesday, December 4, 2024, at 11:45 a.m. Eastern Time.

Kenvue's portfolio includes well-known brands such as Aveeno, BAND-AID, Johnson's, Listerine, Neutrogena, and Tylenol, giving investors a glimpse into the company's diverse product offerings.

The live webcast of the event will be accessible on investors.kenvue.com, allowing interested parties to tune in remotely.

Kenvue has a history of paying dividends to its shareholders, with a notable payment of $0.40 per share in 2023.

The company's dividend payments are listed in its dividend calendar, which shows a payment of $0.40 per share in 2023 with a yield of 1.86%. This payment was made to shareholders of Kenvue Inc Registered Shs.

Kenvue has also declared a quarterly cash dividend of $0.205 per share, which will be payable on February 26, 2025, to shareholders of record as of February 12, 2025.

Here's a breakdown of Kenvue's dividend payments over the years:

Note that the dividend payments for 2022, 2021, 2020, and 2019 were $0, indicating that the company did not pay a dividend during those years.

KVUE stock has seen a previous close of $21.44 and a day range of $21.32 to $21.65.

The market capitalization of KVUE is a substantial $41,106,055,000, and it's listed on the NYSE.

KVUE's stock performance is notable, with a year range of $17 to $24.

Kenvue is making significant strides in its climate action strategy. The company has reduced Scope 1 and 2 greenhouse gas emissions by 26% since 2020.

Renewable electricity is now a major part of Kenvue's energy mix, accounting for 65% of its total electricity consumption.

Kenvue has also made progress in reducing its environmental impact through its packaging. The company has increased the use of recyclable or refillable packaging to 71% of its portfolio.

Reducing virgin plastic in packaging is another key area of focus for Kenvue. The company has successfully reduced virgin plastic in packaging by 21%.

Here's a breakdown of Kenvue's progress in reducing its environmental impact:

The previous close for KVUE stock was $21.44.

This represents a significant milestone in the company's recent history.

The day range for KVUE stock was between $21.32 and $21.65.

This indicates a relatively stable trading day.

The year range for KVUE stock is between $17 and $24.

This shows the stock's value has fluctuated over the past year.

KVUE's market capitalization is a staggering $41,106,055,000.

This massive market cap underscores the company's size and influence.

The primary exchange for KVUE stock is the New York Stock Exchange (NYSE).

This is a well-established and reputable exchange.

Related reading: Michiline Stock Market Quote

Analyst Opinions play a significant role in shaping investor sentiment and influencing stock prices. Analysts from top firms have been following this company closely, and their opinions are worth considering.

Deutsche Bank and J.P. Morgan have both maintained a "Buy" rating for this stock, with Deutsche Bank's target price at $23 and J.P. Morgan's at $22. This suggests that these analysts believe the stock has significant growth potential.

In contrast, Citigroup Corp. has maintained a "Hold" rating, with a target price of $20. This indicates that they see the stock as a relatively stable investment, but not necessarily a high-growth opportunity.

Interestingly, some analysts have downgraded or upgraded their ratings over time. For example, Goldman Sachs downgraded their rating from "Buy" to "Hold" on March 1, 2024, while Deutsche Bank upgraded their rating from "Hold" to "Buy" on September 11, 2023.

Here's a summary of the analyst opinions:

It's worth noting that analyst opinions can change over time, and it's essential to stay up-to-date with the latest ratings and recommendations.